Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BiondVax Pharmaceuticals Ltd. - American Depositary Shares (NQ:BVXV)

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BiondVax Pharmaceuticals Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
New Research Shows Brain Stimulation Improves Reading Ability of Macular Degeneration Patients
Via Investor Brand Network
BioMedNewsBreaks – Aegis Capital Corp. Acted as Sole Bookrunner on BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) $8M Underwritten Public Offering
Via Investor Brand Network
News headline image
Aegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)
Via ACCESSWIRE
Experts Push for More Studies into Link Between Asthma, Female Sex Hormones
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering
Via Investor Brand Network
News headline image
BiondVax Announces Closing of $8 Million Underwritten Public Offering
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
News headline image
Why Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading Session ↗
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading lower by 58.60% to $3.64 during Friday's session after the company priced its 1.6 million unit offering at $5 per unit. 
Via Benzinga
News headline image
Dow Tumbles 400 Points; Maxar Technologies Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Friday. 
Via Benzinga
News headline image
Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. 
Via Benzinga
News headline image
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Pricing on Public Offering, Expects to Raid $8M
Via Investor Brand Network
News headline image
Dow Drops 200 Points; Accenture Posts Upbeat Results ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday. 
Via Benzinga
News headline image
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast
Via Investor Brand Network
Psoriasis Patients Report Being Embarrassed Because of Flare-Ups in Intertriginous Areas
Via Investor Brand Network
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Innovative Inhaled COVID-19 NanoAb Therapy Shows Statistically Significant Efficacy Results in Preclinical Study
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Regains Compliance with Nasdaq Listing Rules
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report
Via Investor Brand Network
Teens Suffering from Concussions Could Benefit from Screen Time
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Names Experienced Researcher as Advisory Board Member
Via Investor Brand Network
News headline image
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q3 2022 Financial Results, Corporate Updates
Via Investor Brand Network
News headline image
BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Confirms Inhalation Concept of NanoAb as Therapy for COVID-19
Via Investor Brand Network
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases
Via Investor Brand Network
News headline image
BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
News headline image
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗
Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. 
Via Benzinga
News headline image
Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08. 
Via Benzinga
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.